CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV
Nasdaq · stock · Hospital & Medical Service Plans · website · IPO 2020-06-12
CLOVER HEALTH INVESTMENTS, CORP. /DE financials (annual)
Bars are annual figures from 2019 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.9B | $1.4B | $1.3B | $1.1B | $1.5B | $672.9M | $462.3M |
| Gross profit | — | — | $257.3M | $70.2M | -$79.2M | — | — |
| Operating income | -$85.5M | -$45.7M | -$205.3M | -$286.7M | -$637.0M | -$92.7M | -$183.2M |
| Interest expense | — | — | $7,000 | $1.3M | $3.2M | $36.0M | $23.2M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$85.5M | -$43.0M | -$213.4M | -$339.6M | -$587.8M | -$136.4M | -$363.7M |
| EPS (diluted) | — | — | $-0.44 | $-0.71 | $-1.42 | $-1.54 | $-4.14 |
| Operating cash flow | -$66.9M | $82.5M | -$144.7M | -$304.6M | -$282.3M | -$118.5M | -$159.9M |
| Free cash flow | -$69.0M | $80.9M | -$145.2M | -$309.1M | -$283.0M | -$119.2M | -$159.9M |
| Cash & equivalents | $78.3M | $194.5M | $122.9M | $103.8M | $300.0M | $92.3M | $67.6M |
| Total assets | $541.0M | $580.7M | $570.7M | $808.6M | $950.8M | $267.3M | $100,346 |
| Total liabilities | $232.3M | $239.6M | $284.3M | $451.7M | $410.8M | $432.7M | $117,977 |
| Shareholders' equity | $308.7M | $341.1M | $286.4M | $356.9M | $540.0M | -$617.1M | -$488.5M |
Growth · year-over-year · Revenue CAGR 26.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue growth | +40.3% | +8.8% | +15.0% | -25.5% | +118.8% | +45.6% | — |
| Free cash flow growth | -185.3% | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.